会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Toll-like receptor 5 ligands and methods of use
    • Toll样受体5配体及使用方法
    • US20050147627A1
    • 2005-07-07
    • US10991347
    • 2004-11-16
    • Alan AderemFumitaka HayashiKelly SmithDavid UnderhillAdrian Ozinsky
    • Alan AderemFumitaka HayashiKelly SmithDavid UnderhillAdrian Ozinsky
    • A61K39/00C07K14/195C07K14/255A61K39/02C12N9/00
    • C07K14/195A61K39/00A61K2039/55516C07K14/255C07K2319/00
    • The invention provides an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ (SEQ ID NO:44), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL (SEQ ID NO:45); EGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLNEIDRVNG (SEQ ID NO:46) or MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS (SEQ ID NO:47), or a modification thereof. Also provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:49) or EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:50), or a modification thereof. Further provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ (SEQ ID NO:44) and substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. Methods of using immunomodulatory flagellin peptides additionally are provided.
    • 本发明提供具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ(SEQ ID NO:44)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节性鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本相同的氨基酸序列TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL(SEQ ID NO:45); 或其修饰物。(SEQ ID NO:46)或MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS(SEQ ID NO:47)或其修饰。 还提供了具有基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本上相同的氨基酸序列TLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:49)或EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:50)或其修饰。 还提供了具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ(SEQ ID NO:44)和基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有类似受体5的氨基酸序列的免疫调节鞭毛蛋白肽 (TLR5)结合。 另外提供了使用免疫调节鞭毛蛋白肽的方法。
    • 4. 发明授权
    • Toll-like receptor 5 ligands and methods of use
    • Toll样受体5配体及使用方法
    • US08703146B2
    • 2014-04-22
    • US10991347
    • 2004-11-16
    • Alan AderemFumitaka HayashiKelly D. SmithDavid M. UnderhillAdrian Ozinsky
    • Alan AderemFumitaka HayashiKelly D. SmithDavid M. UnderhillAdrian Ozinsky
    • A61K39/112
    • C07K14/195A61K39/00A61K2039/55516C07K14/255C07K2319/00
    • The invention provides an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ (SEQ ID NO:44), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL (SEQ ID NO:45); EGALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQRLNEIDRVNG (SEQ ID NO:46) or MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS (SEQ ID NO:47), or a modification thereof. Also provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. The immunomodulatory flagellin peptide also can have substantially the same amino acid sequence TLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:49) or EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS (SEQ ID NO:50), or a modification thereof. Further provided is an immunomodulatory flagellin peptide having substantially the same amino acid sequence GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ (SEQ ID NO:44) and substantially the same amino acid sequence LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL (SEQ ID NO:48), or a modification thereof, and having toll like receptor 5 (TLR5) binding. Methods of using immunomodulatory flagellin peptides additionally are provided.
    • 本发明提供具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAEITQ(SEQ ID NO:44)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本相同的氨基酸序列TQFSGVKVLAQDNTLTIQVGANDGETIDIDLKQINS QTLGLDTL(SEQ ID NO:45); 或其修饰物。(SEQ ID NO:46)或MAQVINTNSLSLLTQNNLNKSQSALGTAIERLSSGLRINSAKDDAAGQAIANF TANIKGLTQASRNANDGISIAQTTEGALNEINNNLQRVRELAVQS(SEQ ID NO:47)或其修饰。 还提供了具有基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有与受体5(TLR5)结合的通路的免疫调节鞭毛蛋白肽。 免疫调节鞭毛蛋白肽也可以具有基本上相同的氨基酸序列TLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:49)或EQAAKTTENPLQKIDAALAQVDTLRSDLGAVQNRFNSAITNLGNTVNNLSS(SEQ ID NO:50)或其修饰。 还提供了具有基本上相同的氨基酸序列GALNEINNNLQRVRELAVQSANSTNSQSDLDSIQAE ITQ(SEQ ID NO:44)和基本上相同的氨基酸序列LQKIDAALAQVDTLRSDLGAVQNRFNSAITNL(SEQ ID NO:48)或其修饰,并具有类似受体5的氨基酸序列的免疫调节鞭毛蛋白肽 (TLR5)结合。 另外提供了使用免疫调节鞭毛蛋白肽的方法。
    • 6. 发明授权
    • Catalyst for hydrogenation treatment and method for hydrogenation treatment of hydrocarbon oil
    • 用于氢化处理的催化剂和烃油的氢化处理方法
    • US06306289B1
    • 2001-10-23
    • US09423833
    • 1999-11-16
    • Fumitaka HayashiAkira KamoHiroshi Toshima
    • Fumitaka HayashiAkira KamoHiroshi Toshima
    • C10G4500
    • B01J23/88B01J21/02B01J21/10B01J21/12B01J23/85B01J23/882B01J23/883B01J35/002B01J35/10B01J35/1019B01J35/108B01J37/0205B01J37/03C10G45/08
    • A hydrotreating catalyst having both a high desulfurization activity and a denitrogenation activity and a method of hydrotreating a hydrocarbon oil using the same is provided. A hydrotreatment catalyst comprising a silica-alumina carrier loaded with at least one hydrogenation-active component; wherein (1) the silica content is in the range of 2 to 40% by weight based on the total weight of the carrier; and (2) in the spectrum obtained by nuclear magnetic resonance analysis (29Si-NMR), (i) the area of the peak at −80 ppm is 10% or more of the combined area of all the peaks; and (ii) the combined area of peaks at −80 ppm, −86 ppm and −92 ppm is 20% or more of the combined area of all peaks; a hydrotreating catalyst comprising a silica-alumina carrier containing a specific amount of a third component loaded with at lest one hydrogenation-active metal component and having a specific pore structure; and a method of hydrotreating a hydrocarbon oil comprising contacting a hydrocarbon oil with hydrogen in the presence of said hydrotreating catalyst.
    • 提供具有高脱硫活性和脱氮活性的加氢处理催化剂,以及使用其加氢处理烃油的方法。一种加氢处理催化剂,其包含负载有至少一种氢化活性组分的二氧化硅 - 氧化铝载体; 其中(1)基于所述载体的总重量,二氧化硅含量在2-40重量%的范围内; 和(2)在通过核磁共振分析(29Si-NMR)获得的光谱中,(i)-80ppm处的峰面积为所有峰的组合面积的10%以上; 和(ii)-80ppm,-86ppm和-92ppm的峰的组合面积为所有峰的组合面积的20%或更多; 加氢处理催化剂,其包含含有特定量的第三组分的二氧化硅 - 氧化铝载体,所述第三组分装载有至少一种氢化活性金属组分并具有特定孔结构; 以及加氢处理烃油的方法,包括在所述加氢处理催化剂存在下使烃油与氢气接触。